SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending after reports surfaced of potential foundry collaboration with Intel, sparking discussions about the implications for competition and domestic chip manufacturing. The community is weighing the potential benefits and risks of this partnership, with some questioning AMD's motives and others speculating about the broader strategic implications for the semiconductor industry. Bullish sentiment is fueled by anticipation of upcoming earnings and the stock's potential to reach new highs.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

CRML is trending amid speculation of a potential U.S. government stake in the company's Greenland rare earths mine, fueled by recent news reports. The community is discussing the potential for a short squeeze and comparing CRML to other government-backed plays. Investors are closely watching the stock's movements and anticipating further news or official confirmation.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood's platform is reportedly experiencing downtime, sparking frustration among users who are unable to manage their positions. The community is actively discussing the app's reliability and potential impact on their investments, with some expressing intentions to switch to alternative platforms. Amidst this, some users speculate on potential partnerships with tech companies and highlight bullish sentiment related to the broader market.

Spruce Biosciences, Inc. is a biopharmaceutical company, which engages in developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. The company was founded on November 13, 2014 and is headquartered in South San Francisco, CA.

Spruce Biosciences Inc

SPRB is trending due to FDA breakthrough therapy designation for its Sanfilippo syndrome treatment, sparking discussions of a potential short squeeze given the stock's low float. The community is actively discussing the news, potential catalysts, and speculating on the stock's next move. Some investors believe the company is significantly undervalued relative to its cash position and pipeline.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

META is trending as investors grapple with its recent dip despite broader market gains, with some citing concerns over heavy AI spending and competition while others see it as a buying opportunity after the stock filled a gap from a previous earnings report. Community discussions revolve around whether the pullback is an overreaction and if the stock is poised for a bounce, with speculation about upcoming earnings and the potential impact of new AI-driven initiatives.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

LKNCY is trending as investors discuss the company's potential to surpass Starbucks, driven by its innovative approach and expansion into the U.S. market. Community members are closely watching for a breakout above the $40 mark, with some anticipating a Nasdaq relisting. Bullish sentiment is fueled by the company's strong growth in China and increasing global presence.

HIVE Digital Technologies Ltd. engages in building a bridge between the digital currency and blockchain sector and traditional capital markets. It operates data centers for computing and mining cryptocurrencies, including Bitcoin and other coins. The firm owns and operates green energy-powered data center facilities in Canada, Sweden, and Iceland. Its project includes Iceland Cryptocurrency Mining. HIVE Digital Technologies was founded on June 24, 1987 and is headquartered in San Antonio, TX.

HIVE Digital Technologies Ltd.

HIVE Digital Technologies Ltd

HIVE Digital Technologies is trending as investors discuss its undervaluation compared to peers, especially regarding its Bitcoin mining and AI infrastructure. Community members are highlighting the company's increasing hash rate, efficient operations, and expansion into high-performance computing, generating optimism about revenue growth and future potential. Some are drawing comparisons to other miners like IREN and anticipating a significant price increase soon.

Ethereum is a global, open-source platform for decentralized applications. In other words, the vision is to create a world computer that anyone can build applications in a decentralized manner; while all states and data are distributed and publicly accessible. Ethereum supports smart contracts in which developers can write code in order to program digital value. Examples of decentralized apps (dapps) that are built on Ethereum includes tokens, non-fungible tokens, decentralized finance apps, lending protocol, decentralized exchanges, and much more.  On Ethereum, all transactions and smart contract executions require a small fee to be paid. This fee is called Gas. In technical terms, Gas refers to the unit of measure on the amount of computational effort required to execute an operation or a smart contract. The more complex the execution operation is, the more gas is required to fulfill that operation. Gas fees are paid entirely in Ether (ETH), which is the native coin of the blockchain. The price of gas can fluctuate from time to time depending on the network demand.

Ethereum

Ethereum is trending as the community anticipates potential staking ETFs and discusses institutional adoption from Grayscale, Fidelity, and BlackRock. Conversations revolve around Ethereum reaching $5K soon, with some bullish investors predicting it could climb as high as $15K by the end of the year. The possibility of multiple consecutive 10% gain days is also fueling excitement.

Eos Energy Enterprises, Inc. designs, manufactures, and deploys battery storage solutions for the electricity industry. It offers the Eos Znyth DC battery system product which designs to meet the requirements of the grid-scale energy storage market. The company was founded in 2008 and is headquartered in Edison, NJ.

Eos Energy Enterprises Inc - Ordinary Shares - Class A

EOSE is trending due to renewed investor interest in energy storage solutions, particularly those supporting AI and data centers, with discussions highlighting the company's potential as a key player. Community members are actively discussing its American-made advantage, potential for a short squeeze, and comparing it to sector peers. Recent analyst upgrades and positive technical indicators appear to be contributing to the upward momentum.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending as the community rallies around a potential moonshot, fueled by meme-driven enthusiasm and a focus on community building. Talk centers on expressing their 'rage' and anticipation for significant upward movement, while some users highlight the coin's potential and strong community. The coin is also drawing attention from other meme coins.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Lyra Therapeutics, Inc. (LYRA) Reports Q2 Loss, Beats Revenue Estimates

Lyra Therapeutics (LYRA) delivered earnings and revenue surprises of +4.84% and +26.21%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Heron Therapeutics (HRTX) Reports Q2 Loss, Misses Revenue Estimates

Heron Therapeutics (HRTX) delivered earnings and revenue surprises of -100.00% and -1.89%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Lyra Therapeutics (LYRA) Upgraded to Buy: Here's Why

Lyra Stock Soars 356% in a Week on Strong Rhinosinusitis Study Success

Shares of Lyra Therapeutics, Inc. (LYRA) rocketed 370% on Monday after the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://investors.lyratherapeutics.com/news-releases/news-release-details/lyra-therapeutics-reports-positive-results-enlighten-2-phase-3">announced</a> positive results from its late-stage clinical trial of LYR-210 in adult patients with chronic rhinosinusitis.LYR-210 is an investigational bioabsorbable nasal implant for the treatment of chronic rhinosinusitis (CRS) in patients who have failed current therapies and require further intervention.It is designed to be inserted in a simple, in-office procedure and intended to deliver six months of continuous anti-inflammatory therapy, mometasone furoate, to the sinonasal passages to treat CRS.LYR-210 demonstrated statistically significant improvement compared to sham control in key symptoms of chronic rhinosinusitis, such as nasal obstruction, nasal discharge, and facial pain/pressure at week 24 in patients with or without nasal polyps in the trial, the company said.The trial enrolled approximately 180 CRS patients who had not had prior ethmoid sinus surgery. While some received the company’s lead product, others received a sham control.The implant was well-tolerated, and most commonly reported adverse events included epistaxis, upper respiratory tract infection, chronic sinusitis, acute sinusitis, nasopharyngitis, COVID-19, and headache, the company added.Lyra said that its therapy is expected to help the estimated four million CRS patients in the United States who fail medical management each year.Lyra CEO Maria Palasis stated that the company now plans to align with the FDA on the path forward for submitting a new drug application.The company had previously conducted a late-stage study for the implant, which did not meet its goals.On Stocktwits, retail sentiment around Lyra jumped from ‘bearish’ to ‘extremely bullish’ over the past 24 hours while message volume rose from ‘normal’ to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:630/62;" src="https://news.stocktwits-cdn.com/Screenshot_2025_06_02_at_2_05_49_PM_png_c936942df7.webp" alt="LYRA's Sentiment Meter and Message Volume as of 2:05 p.m. ET on June 2, 2025 | Source: Stocktwits" width="630" height="62"><figcaption>LYRA's Sentiment Meter and Message Volume as of 2:05 p.m. ET on June 2, 2025 | Source: Stocktwits</figcaption></figure> <a href="https://stocktwits.com/symbol/LYRA">LYRA stock</a> is up by about 116% this year and by about 43% over the past 12 months.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/crowdstrike-and-microsoft-team-up-to-simplify-cyber-threat-intelligence/chkYeQARbH1">CrowdStrike And Microsoft Team Up To Simplify Cyber Threat Intelligence: Retail’s Buoyant</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Lyra Therapeutics Stock Skyrockets On Positive Trial Data For Its Nasal Implant: Retail’s Thrilled

LYR-210 demonstrated statistically significant improvement compared to sham control in key symptoms of chronic rhinosinusitis, such as nasal obstruction, nasal discharge, and facial pain/pressure at week 24. 

Equity

LYR-210 demonstrated statistically significant improvement compared to sham control in key symptoms of chronic rhinosinusitis, such as nasal obstruction, nasal discharge, and facial pain/pressure at week 24. 


Lyra Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)

Latest Ratings for LYRA
 DateFirmActionFromTo May 2020B of A SecuritiesInitiates Coverage OnBuy May 2020JefferiesInitiates Coverage OnBuy
 View More Analyst Ratings for LYRA

 View the...

Why Lyra Therapeutics Stock Is Down 93% Today

Lyra Therapeutics shares are trading lower by 93% to $0.30 during Monday's session. The company announced the ENLIGHTEN 1 trial did not meet its primary endpoint.
read more...

The volume for Lyra Therapeutics stock increased for one day, resulting in a record-breaking daily growth of 516% of the 65-Day Volume Moving Average

LYRA's total volume now sits at 2M. The +0.16% price change was insignificant, leaving IBM's price at $6.23...

Lyra Therapeutics (LYRA, $6.13) entered Downtrend as Momentum indicator drops below 0 level on Mar 26, 2024

This indicator may be signaling that LYRA's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

The volume for Lyra Therapeutics stock increased for three consecutive days, resulting in a record-breaking daily growth of 187% of the 65-Day Volume Moving Average

LYRA's total volume now sits at 700.8K. The +0.99% average daily price change was insignificant these 3 days, leaving LYRA's price at $6.13...

Lyra Therapeutics, Inc. is a clinical-stage therapeutics company. It develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases. The firms proprietary XTreo deliver medicines. The company was founded by Carmichael S. Roberts, George M. Whitesides, and Robert S. Langer in November 2005 and is headquartered in Watertown, MA.

Lyra Therapeutics Inc

Will PepsiCo ($PEP) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

PepsiCo Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	-$5.26	--	--	N/A
Q2 '25	-$5.53	-$5.51	0.30%	BEAT
Q1 '25	-$0.15	-$6.50	-4233.33%	MISSED
Q4 '24	-$0.12	-$0.16	-33.33%	MISSED
Q3 '24	-$0.22	-$0.18	16.28%	BEAT

LYRA
Lyra Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q2 '25

Historical Earnings

Latest LYRA News

LYRA Lyra Therapeutics Inc